Back

Electroanatomical properties of the superior vena cava - the vein, born for isolation.

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Mapping and imaging in arrhythmia management Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Ms Hannah Budke

Kiel (Germany)

6 More presentations in this session

Presentation thumbnail
In-vivo endocardial and epicardial mapping of human sinus node: from electrical landmarks to anatomical landmarks
Professor C. de Asmundis (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
Distributions of epicardial adipose tissue in atrial fibrillation using photon counting CT and 3D atrial segmentation: Insights from the Prospective AFAT Study
Doctor N. Erhard (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Real-time MR-guided radiofrequency ablation and lesion evaluation in an MRI-compatible isolated beating pig heart platform
Mr L. Hopman (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Markers of atrial myopathy in the UK Biobank: prevalence, consequences, and risk stratification
Mr O. Vad (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Electroanatomic Characteristics and prediction of de novo atypical atrial flutter using deep learning algorithm
Mr A. Mann (Himachal Pradesh, IN)
Abstract Slides Video

Access the full session

Session thumbnail
Mapping and imaging in arrhythmia management
Video

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Superior vena cava isolation in paroxysmal atrial fibrillation - mind the phrenic
thumbnail
Congress Presentation
Prevalance of incessant form of atrial fibrillation by superior vena cava (svc) firing: simplified svc and sinus node mapping(sss map) to avoid sinus node injury.
thumbnail
Congress Presentation
Superior vena cava isolation in addition to standard pulmonary vein isolation by fourth-generation cryoballoon for paroxysmal atrial fibrillation - mid-term outcomes of a randomized trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources